James Limberis

James Limberis has over 20 years of experience in the pharmaceutical industry. James is currently working as a Sr. Scientist at Rapport Therapeutics since February 2023. Prior to this, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson for 4 years, starting as a Sr. Assoc. Scientist in April 2019 and later promoted to Scientist in September 2022. Before that, they worked as a Senior Scientist at Photoswitch Biosciences, Inc. from February 2018 to March 2019. James also worked as an Associate Fellow at Dart NeuroScience LLC from May 2017 to February 2018. James started their career at Gilead Sciences as an Electrophysiologist in December 2014 and continued working there until February 2017. James also worked as an Electrophysiologist at Dart Neuroscience from February 2011 to December 2014. Prior to that, they worked at Abbott Laboratories as a Scientist from September 2003 to February 2011, where they conducted in-vitro cardiac safety testing and assisted project teams in assessing compounds for cardiac effects. Before Abbott Laboratories, James worked at Pharmacia/Pfizer as a Research Scientist from February 2002 to August 2003, where they conducted cardiac safety testing and used various electrophysiology techniques. James started their career at Purdue Pharma as an Associate Senior Scientist from April 2000 to January 2002, where they assessed compounds for the treatment of neuropathic pain using electrophysiology techniques.

James Limberis has a degree in Biological Sciences from the University of Chicago. No specific start or end years for their education are mentioned.